MétaCan
Menu
Back to cohort

Validation of heart failure prediction tool in cardio-oncology breast cancer population.

2015· article· en· W2921002359 on OpenAlexaff
Moira Rushton, Freya Crawley, Wyanne Law, Nadine Graham, Christopher Johnson, Jeffrey Sulpher, Susan Dent

Bibliographic record

VenueJournal of Clinical Oncology · 2015
Typearticle
Languageen
FieldMedicine
TopicChemotherapy-induced cardiotoxicity and mitigation
Canadian institutionsOttawa HospitalUniversity of Ottawa
Fundersnot available
KeywordsMedicineBreast cancerInternal medicinePopulationTrastuzumabFramingham Risk ScoreOncologyHeart failureCardiomyopathyCancerDisease

Abstract

fetched live from OpenAlex

e17693 Background: While advances in breast cancer treatment, including targeted therapies such as trastuzumab have improved patient outcomes, short and long-term cardio-toxicity is a recognized risk. A clinical risk score (CRS) based on clinical risk factors has been derived for breast cancer (BC) patients (Ezaz et al, 2014), but remains untested in a real world clinical population. The objectives of this study are to apply this CRS to a real world breast cancer (BC) population seen in a dedicated cardio-oncology referral clinic (CORC) and correlate predicted versus actual risk of congestive heart failure (CHF) and cardiomyopathy (CM). Methods: BC patients referred to the CORC between October 2008 and August 2014 were reviewed retrospectively. Data was collected on patient demographics, cardiac risk factors, cardiac testing and outcomes. A CRS was calculated for each patient. Sensitivity, specificity, positive and negative predictive values of this risk score were evaluated using CHF/CM as the end-point. Results: 337 BC patients were reviewed; 14 were excluded because of missing data. Median age was 56 years old (range 25 - 87, SD 12); 217 (66%) had early stage (I-II) disease; 214 (66%) were ER positive; 181 (56%) were PR positive; and 199 (62%) were Her2 positive. 93% (n = 301) received adjuvant chemotherapy and 63% (n = 203) received targeted agents. Applying the CRS found 194 (60%) would be considered low risk to develop CHF/CM; 78 (24%) moderate risk; and 51 (16%) high risk. When applied to this population, the high-risk score cut-off had a 30.2% sensitivity (CI 18.7 – 44.5%) and 87.0% specificity (CI 82.2 % - 90.6%). Positive predictive value is 0.314 (CI 0.195 – 0.460) and negative predictive value is 0.86 (CI 0.816 – 0.901). Conclusions: This CRS has modest positive predictive value and good negative predictive value for CHF and CM in a contemporary sample of breast cancer patients. Patients with a high CRS may benefit from more intense cardiac evaluation in a clinic such as our CORC, since almost half of these patients develop CHF or CM. Most patients have a low or moderate CRS, and a lower risk of CHF/CM. Future work combining clinical risk scores with cardiac imaging and biomarkers may better predict cardiac risk during breast cancer therapy.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.013
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.004
Threshold uncertainty score0.021

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0040.013
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0020.001
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.104
GPT teacher head0.449
Teacher spread0.345 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2015
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical OncologySame topicChemotherapy-induced cardiotoxicity and mitigationFrench-language works237,207